Altimmune, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
27.75
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
4
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.50
|
-0.48
|
0.02
|
4.00%
|
|
2022-06-30
|
-0.47
|
-0.42
|
0.05
|
10.64%
|
|
2022-03-31
|
-0.58
|
-0.44
|
0.14
|
24.14%
|
|
2021-12-31
|
-0.65
|
-0.57
|
0.08
|
12.31%
|
|
2021-09-30
|
-0.39
|
-0.81
|
-0.42
|
-107.69%
|
|
2021-06-30
|
-0.50
|
-0.60
|
-0.10
|
-20.00%
|
|
2021-03-31
|
-0.47
|
-0.38
|
0.09
|
19.15%
|
|
2020-12-31
|
-0.75
|
-0.17
|
0.58
|
77.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.34
|
|
2021-12-31
|
-2.36
|
|
2020-12-31
|
-1.91
|
|
2019-12-31
|
-1.51
|
|
2018-12-31
|
-16.98
|
|
2017-12-31
|
-79.84
|
|
2016-12-31
|
0.00
|
|
2015-12-31
|
0.00
|
|
2014-12-31
|
-39.00
|
|
2013-12-31
|
-66.00
|
|
2012-12-31
|
-31.33
|
|
2011-12-31
|
-24.21
|
|
2010-12-31
|
-330.00
|
|
2009-12-31
|
-351.00
|
|
2008-12-31
|
-489.05
|
|
2006-12-31
|
-11878.40
|
|
2005-12-31
|
4.81
|